Reservoir Neuroscience is an Emeryville, CA-based, early-stage venture-backed biotech led by co-founders Aaron Friedman and Vlad Senatorov. The company is advancing a novel class of drug compounds designed to restore health to the brain’s blood vessels to rejuvenate the aging brain. It targets brain vascular pathology that becomes damaged and dysfunctional with aging and drives inflammation and neurodegenerative disease outcomes. Reservoir positions this vascular pathology as a biomarker that defines a patient segment and a previously untreated target. The firm intends to use its new financing to develop these compounds further. Company leadership states that treating underlying vascular problems could address a major risk factor for neurodegenerative disease and may offer broader brain-health and systemic benefits.

Total raised

$4M

Funding rounds

1

Latest round

Equity

Latest activity

Jan 2024